Idiopathic Pneumonia Syndrome in Mice after Allogeneic Bone Marrow Transplantation

Pulmonary complications are a major clinical problem following allogeneic bone marrow transplantation (BMT), contributing to more than 30% of transplant-related mortalities. Idiopathic pneumonia syndrome is responsible for significant mortality among BMT patients. However, the etiology of injury to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of respiratory cell and molecular biology 1998-02, Vol.18 (2), p.235-242
Hauptverfasser: Shankar, Gopi, Scott Bryson, J, Darrell Jennings, C, Morris, Peter E, Cohen, Donald A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 242
container_issue 2
container_start_page 235
container_title American journal of respiratory cell and molecular biology
container_volume 18
creator Shankar, Gopi
Scott Bryson, J
Darrell Jennings, C
Morris, Peter E
Cohen, Donald A
description Pulmonary complications are a major clinical problem following allogeneic bone marrow transplantation (BMT), contributing to more than 30% of transplant-related mortalities. Idiopathic pneumonia syndrome is responsible for significant mortality among BMT patients. However, the etiology of injury to the lung parenchyma by this disease syndrome is unknown and it has been difficult to evaluate the cellular and molecular mechanisms underlying IPS in the absence of a suitable animal model. To study post-BMT lung disease during graft-versus-host disease (GVHD), we have developed a murine model that utilizes a semi-allogeneic parental --> F1 transplant strategy to induce a mild form of GVHD. Progressive inflammatory lung disease developed in animals with mild GVHD, as indicated by changes in immune cell distribution and cytokine expression in the lungs of transplanted animals. Histologic analysis of lung tissue from GVHD mice at 3 wk post-BMT showed minor immunopathologic changes compared with control mice. In contrast, lungs of GVHD mice at 12 wk displayed histopathologic hallmarks of interstitial pneumonitis, such as prominent perilumenal mononuclear cell infiltration and areas of alveolar congestion. Flow cytometric analysis of lung interstitial cells of GVHD mice revealed an increase in CD8+ T-cells at week 3, which decreased to normal levels by week 12 post-BMT. Simultaneously, the percentage of CD4+ T-cells increased progressively above normal levels and peaked at week 7 post-BMT. Analysis of cytokine mRNA expression in lung tissue indicated that steady state levels of interleukin (IL)-1beta, tumor necrosis factor (TNF)-alpha, interferon-gamma, and IL-12 were significantly elevated in lungs of GVHD mice at 3 wk post-BMT compared with untreated controls. Mice that were transplanted with allogeneic bone marrow alone (BMT controls) also displayed elevated expression of these cytokines, although only IL-6 was significantly higher than in untreated controls. In contrast, at 12 wk after transplantation only TNF-alpha and IL-12 levels remained elevated in GVHD mice, suggesting prolonged macrophage activation. On the basis of these findings, we conclude that allogeneic bone marrow transplantation in this mouse model causes a progressive interstitial pneumonitis, which is characterized by an acute influx of CD8+ T-cells, followed in the chronic phase by a prominent accumulation of CD4+ T-cells, and is associated with persistent production of cytokines known to activ
doi_str_mv 10.1165/ajrcmb.18.2.2988
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79692334</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79692334</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-3f395c0e3d0f32ee21af797859ccb5da3506b893bef4bdff2f75704db37bea393</originalsourceid><addsrcrecordid>eNpdkElr5DAQRkXIkP2eS8DkMOTiHq22dUzCZIE0M2Q5C1kupdXYUkeyCfn3o8ZNDnOqgnrfR_EQOid4QUglful1NEO7IM2CLqhsmj10RAQTJZeN3M875rwkgstDdJzSGmNCG0IO0IHkdSUJOULPj50LGz2unCn-epiG4J0uXr58F8MAhfPF0hkotB0hFtd9H97BQ2ZvgodiqWMMn8Vr1D5teu1HPbrgT9EPq_sEZ7t5gt7ufr_ePpRPf-4fb6-fSsMpHktmmRQGA-uwZRSAEm1rWTdCGtOKTjOBq7aRrAXL285aamtRY961rG5BM8lO0M-5dxPDxwRpVINLBvr8CIQpqVpWkjLGM3j5H7gOU_T5N0VxXYlskmUIz5CJIaUIVm2iG3T8UgSrrWs1u1akUVRtXefIxa53agfovgM7ufl-Nd9X7n316SKoNOi-zzTZlc1dTLB_UNWKKg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>207651163</pqid></control><display><type>article</type><title>Idiopathic Pneumonia Syndrome in Mice after Allogeneic Bone Marrow Transplantation</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><source>Journals@Ovid Complete</source><creator>Shankar, Gopi ; Scott Bryson, J ; Darrell Jennings, C ; Morris, Peter E ; Cohen, Donald A</creator><creatorcontrib>Shankar, Gopi ; Scott Bryson, J ; Darrell Jennings, C ; Morris, Peter E ; Cohen, Donald A</creatorcontrib><description>Pulmonary complications are a major clinical problem following allogeneic bone marrow transplantation (BMT), contributing to more than 30% of transplant-related mortalities. Idiopathic pneumonia syndrome is responsible for significant mortality among BMT patients. However, the etiology of injury to the lung parenchyma by this disease syndrome is unknown and it has been difficult to evaluate the cellular and molecular mechanisms underlying IPS in the absence of a suitable animal model. To study post-BMT lung disease during graft-versus-host disease (GVHD), we have developed a murine model that utilizes a semi-allogeneic parental --&gt; F1 transplant strategy to induce a mild form of GVHD. Progressive inflammatory lung disease developed in animals with mild GVHD, as indicated by changes in immune cell distribution and cytokine expression in the lungs of transplanted animals. Histologic analysis of lung tissue from GVHD mice at 3 wk post-BMT showed minor immunopathologic changes compared with control mice. In contrast, lungs of GVHD mice at 12 wk displayed histopathologic hallmarks of interstitial pneumonitis, such as prominent perilumenal mononuclear cell infiltration and areas of alveolar congestion. Flow cytometric analysis of lung interstitial cells of GVHD mice revealed an increase in CD8+ T-cells at week 3, which decreased to normal levels by week 12 post-BMT. Simultaneously, the percentage of CD4+ T-cells increased progressively above normal levels and peaked at week 7 post-BMT. Analysis of cytokine mRNA expression in lung tissue indicated that steady state levels of interleukin (IL)-1beta, tumor necrosis factor (TNF)-alpha, interferon-gamma, and IL-12 were significantly elevated in lungs of GVHD mice at 3 wk post-BMT compared with untreated controls. Mice that were transplanted with allogeneic bone marrow alone (BMT controls) also displayed elevated expression of these cytokines, although only IL-6 was significantly higher than in untreated controls. In contrast, at 12 wk after transplantation only TNF-alpha and IL-12 levels remained elevated in GVHD mice, suggesting prolonged macrophage activation. On the basis of these findings, we conclude that allogeneic bone marrow transplantation in this mouse model causes a progressive interstitial pneumonitis, which is characterized by an acute influx of CD8+ T-cells, followed in the chronic phase by a prominent accumulation of CD4+ T-cells, and is associated with persistent production of cytokines known to activate macrophages.</description><identifier>ISSN: 1044-1549</identifier><identifier>EISSN: 1535-4989</identifier><identifier>DOI: 10.1165/ajrcmb.18.2.2988</identifier><identifier>PMID: 9476911</identifier><identifier>CODEN: AJRBEL</identifier><language>eng</language><publisher>United States: Am Thoracic Soc</publisher><subject>AIDS/HIV ; Animals ; Body Weight ; Bone Marrow Transplantation - adverse effects ; CD4-Positive T-Lymphocytes - immunology ; CD8-Positive T-Lymphocytes - immunology ; Cell Transplantation ; Cytokines - genetics ; Disease Models, Animal ; Graft vs Host Disease - complications ; Graft vs Host Disease - immunology ; Graft vs Host Disease - pathology ; Lung - chemistry ; Lung - immunology ; Lung - pathology ; Lung Diseases, Interstitial - etiology ; Lung Diseases, Interstitial - immunology ; Lung Diseases, Interstitial - pathology ; Mice ; Mice, Inbred C57BL ; Organ Size ; RNA, Messenger - analysis ; Spleen - cytology ; Spleen - pathology ; Transplantation, Homologous</subject><ispartof>American journal of respiratory cell and molecular biology, 1998-02, Vol.18 (2), p.235-242</ispartof><rights>Copyright American Lung Association Feb 1998</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-3f395c0e3d0f32ee21af797859ccb5da3506b893bef4bdff2f75704db37bea393</citedby><cites>FETCH-LOGICAL-c420t-3f395c0e3d0f32ee21af797859ccb5da3506b893bef4bdff2f75704db37bea393</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9476911$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shankar, Gopi</creatorcontrib><creatorcontrib>Scott Bryson, J</creatorcontrib><creatorcontrib>Darrell Jennings, C</creatorcontrib><creatorcontrib>Morris, Peter E</creatorcontrib><creatorcontrib>Cohen, Donald A</creatorcontrib><title>Idiopathic Pneumonia Syndrome in Mice after Allogeneic Bone Marrow Transplantation</title><title>American journal of respiratory cell and molecular biology</title><addtitle>Am J Respir Cell Mol Biol</addtitle><description>Pulmonary complications are a major clinical problem following allogeneic bone marrow transplantation (BMT), contributing to more than 30% of transplant-related mortalities. Idiopathic pneumonia syndrome is responsible for significant mortality among BMT patients. However, the etiology of injury to the lung parenchyma by this disease syndrome is unknown and it has been difficult to evaluate the cellular and molecular mechanisms underlying IPS in the absence of a suitable animal model. To study post-BMT lung disease during graft-versus-host disease (GVHD), we have developed a murine model that utilizes a semi-allogeneic parental --&gt; F1 transplant strategy to induce a mild form of GVHD. Progressive inflammatory lung disease developed in animals with mild GVHD, as indicated by changes in immune cell distribution and cytokine expression in the lungs of transplanted animals. Histologic analysis of lung tissue from GVHD mice at 3 wk post-BMT showed minor immunopathologic changes compared with control mice. In contrast, lungs of GVHD mice at 12 wk displayed histopathologic hallmarks of interstitial pneumonitis, such as prominent perilumenal mononuclear cell infiltration and areas of alveolar congestion. Flow cytometric analysis of lung interstitial cells of GVHD mice revealed an increase in CD8+ T-cells at week 3, which decreased to normal levels by week 12 post-BMT. Simultaneously, the percentage of CD4+ T-cells increased progressively above normal levels and peaked at week 7 post-BMT. Analysis of cytokine mRNA expression in lung tissue indicated that steady state levels of interleukin (IL)-1beta, tumor necrosis factor (TNF)-alpha, interferon-gamma, and IL-12 were significantly elevated in lungs of GVHD mice at 3 wk post-BMT compared with untreated controls. Mice that were transplanted with allogeneic bone marrow alone (BMT controls) also displayed elevated expression of these cytokines, although only IL-6 was significantly higher than in untreated controls. In contrast, at 12 wk after transplantation only TNF-alpha and IL-12 levels remained elevated in GVHD mice, suggesting prolonged macrophage activation. On the basis of these findings, we conclude that allogeneic bone marrow transplantation in this mouse model causes a progressive interstitial pneumonitis, which is characterized by an acute influx of CD8+ T-cells, followed in the chronic phase by a prominent accumulation of CD4+ T-cells, and is associated with persistent production of cytokines known to activate macrophages.</description><subject>AIDS/HIV</subject><subject>Animals</subject><subject>Body Weight</subject><subject>Bone Marrow Transplantation - adverse effects</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>Cell Transplantation</subject><subject>Cytokines - genetics</subject><subject>Disease Models, Animal</subject><subject>Graft vs Host Disease - complications</subject><subject>Graft vs Host Disease - immunology</subject><subject>Graft vs Host Disease - pathology</subject><subject>Lung - chemistry</subject><subject>Lung - immunology</subject><subject>Lung - pathology</subject><subject>Lung Diseases, Interstitial - etiology</subject><subject>Lung Diseases, Interstitial - immunology</subject><subject>Lung Diseases, Interstitial - pathology</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Organ Size</subject><subject>RNA, Messenger - analysis</subject><subject>Spleen - cytology</subject><subject>Spleen - pathology</subject><subject>Transplantation, Homologous</subject><issn>1044-1549</issn><issn>1535-4989</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkElr5DAQRkXIkP2eS8DkMOTiHq22dUzCZIE0M2Q5C1kupdXYUkeyCfn3o8ZNDnOqgnrfR_EQOid4QUglful1NEO7IM2CLqhsmj10RAQTJZeN3M875rwkgstDdJzSGmNCG0IO0IHkdSUJOULPj50LGz2unCn-epiG4J0uXr58F8MAhfPF0hkotB0hFtd9H97BQ2ZvgodiqWMMn8Vr1D5teu1HPbrgT9EPq_sEZ7t5gt7ufr_ePpRPf-4fb6-fSsMpHktmmRQGA-uwZRSAEm1rWTdCGtOKTjOBq7aRrAXL285aamtRY961rG5BM8lO0M-5dxPDxwRpVINLBvr8CIQpqVpWkjLGM3j5H7gOU_T5N0VxXYlskmUIz5CJIaUIVm2iG3T8UgSrrWs1u1akUVRtXefIxa53agfovgM7ufl-Nd9X7n316SKoNOi-zzTZlc1dTLB_UNWKKg</recordid><startdate>19980201</startdate><enddate>19980201</enddate><creator>Shankar, Gopi</creator><creator>Scott Bryson, J</creator><creator>Darrell Jennings, C</creator><creator>Morris, Peter E</creator><creator>Cohen, Donald A</creator><general>Am Thoracic Soc</general><general>American Thoracic Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>19980201</creationdate><title>Idiopathic Pneumonia Syndrome in Mice after Allogeneic Bone Marrow Transplantation</title><author>Shankar, Gopi ; Scott Bryson, J ; Darrell Jennings, C ; Morris, Peter E ; Cohen, Donald A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-3f395c0e3d0f32ee21af797859ccb5da3506b893bef4bdff2f75704db37bea393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>AIDS/HIV</topic><topic>Animals</topic><topic>Body Weight</topic><topic>Bone Marrow Transplantation - adverse effects</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>Cell Transplantation</topic><topic>Cytokines - genetics</topic><topic>Disease Models, Animal</topic><topic>Graft vs Host Disease - complications</topic><topic>Graft vs Host Disease - immunology</topic><topic>Graft vs Host Disease - pathology</topic><topic>Lung - chemistry</topic><topic>Lung - immunology</topic><topic>Lung - pathology</topic><topic>Lung Diseases, Interstitial - etiology</topic><topic>Lung Diseases, Interstitial - immunology</topic><topic>Lung Diseases, Interstitial - pathology</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Organ Size</topic><topic>RNA, Messenger - analysis</topic><topic>Spleen - cytology</topic><topic>Spleen - pathology</topic><topic>Transplantation, Homologous</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shankar, Gopi</creatorcontrib><creatorcontrib>Scott Bryson, J</creatorcontrib><creatorcontrib>Darrell Jennings, C</creatorcontrib><creatorcontrib>Morris, Peter E</creatorcontrib><creatorcontrib>Cohen, Donald A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of respiratory cell and molecular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shankar, Gopi</au><au>Scott Bryson, J</au><au>Darrell Jennings, C</au><au>Morris, Peter E</au><au>Cohen, Donald A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Idiopathic Pneumonia Syndrome in Mice after Allogeneic Bone Marrow Transplantation</atitle><jtitle>American journal of respiratory cell and molecular biology</jtitle><addtitle>Am J Respir Cell Mol Biol</addtitle><date>1998-02-01</date><risdate>1998</risdate><volume>18</volume><issue>2</issue><spage>235</spage><epage>242</epage><pages>235-242</pages><issn>1044-1549</issn><eissn>1535-4989</eissn><coden>AJRBEL</coden><abstract>Pulmonary complications are a major clinical problem following allogeneic bone marrow transplantation (BMT), contributing to more than 30% of transplant-related mortalities. Idiopathic pneumonia syndrome is responsible for significant mortality among BMT patients. However, the etiology of injury to the lung parenchyma by this disease syndrome is unknown and it has been difficult to evaluate the cellular and molecular mechanisms underlying IPS in the absence of a suitable animal model. To study post-BMT lung disease during graft-versus-host disease (GVHD), we have developed a murine model that utilizes a semi-allogeneic parental --&gt; F1 transplant strategy to induce a mild form of GVHD. Progressive inflammatory lung disease developed in animals with mild GVHD, as indicated by changes in immune cell distribution and cytokine expression in the lungs of transplanted animals. Histologic analysis of lung tissue from GVHD mice at 3 wk post-BMT showed minor immunopathologic changes compared with control mice. In contrast, lungs of GVHD mice at 12 wk displayed histopathologic hallmarks of interstitial pneumonitis, such as prominent perilumenal mononuclear cell infiltration and areas of alveolar congestion. Flow cytometric analysis of lung interstitial cells of GVHD mice revealed an increase in CD8+ T-cells at week 3, which decreased to normal levels by week 12 post-BMT. Simultaneously, the percentage of CD4+ T-cells increased progressively above normal levels and peaked at week 7 post-BMT. Analysis of cytokine mRNA expression in lung tissue indicated that steady state levels of interleukin (IL)-1beta, tumor necrosis factor (TNF)-alpha, interferon-gamma, and IL-12 were significantly elevated in lungs of GVHD mice at 3 wk post-BMT compared with untreated controls. Mice that were transplanted with allogeneic bone marrow alone (BMT controls) also displayed elevated expression of these cytokines, although only IL-6 was significantly higher than in untreated controls. In contrast, at 12 wk after transplantation only TNF-alpha and IL-12 levels remained elevated in GVHD mice, suggesting prolonged macrophage activation. On the basis of these findings, we conclude that allogeneic bone marrow transplantation in this mouse model causes a progressive interstitial pneumonitis, which is characterized by an acute influx of CD8+ T-cells, followed in the chronic phase by a prominent accumulation of CD4+ T-cells, and is associated with persistent production of cytokines known to activate macrophages.</abstract><cop>United States</cop><pub>Am Thoracic Soc</pub><pmid>9476911</pmid><doi>10.1165/ajrcmb.18.2.2988</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1044-1549
ispartof American journal of respiratory cell and molecular biology, 1998-02, Vol.18 (2), p.235-242
issn 1044-1549
1535-4989
language eng
recordid cdi_proquest_miscellaneous_79692334
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection; Journals@Ovid Complete
subjects AIDS/HIV
Animals
Body Weight
Bone Marrow Transplantation - adverse effects
CD4-Positive T-Lymphocytes - immunology
CD8-Positive T-Lymphocytes - immunology
Cell Transplantation
Cytokines - genetics
Disease Models, Animal
Graft vs Host Disease - complications
Graft vs Host Disease - immunology
Graft vs Host Disease - pathology
Lung - chemistry
Lung - immunology
Lung - pathology
Lung Diseases, Interstitial - etiology
Lung Diseases, Interstitial - immunology
Lung Diseases, Interstitial - pathology
Mice
Mice, Inbred C57BL
Organ Size
RNA, Messenger - analysis
Spleen - cytology
Spleen - pathology
Transplantation, Homologous
title Idiopathic Pneumonia Syndrome in Mice after Allogeneic Bone Marrow Transplantation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T00%3A48%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Idiopathic%20Pneumonia%20Syndrome%20in%20Mice%20after%20Allogeneic%20Bone%20Marrow%20Transplantation&rft.jtitle=American%20journal%20of%20respiratory%20cell%20and%20molecular%20biology&rft.au=Shankar,%20Gopi&rft.date=1998-02-01&rft.volume=18&rft.issue=2&rft.spage=235&rft.epage=242&rft.pages=235-242&rft.issn=1044-1549&rft.eissn=1535-4989&rft.coden=AJRBEL&rft_id=info:doi/10.1165/ajrcmb.18.2.2988&rft_dat=%3Cproquest_cross%3E79692334%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=207651163&rft_id=info:pmid/9476911&rfr_iscdi=true